Bill Clinton Quotes

It’s our tax dollars that fund the initial research for these molecules that get transferred to corporations. We have an investment here… We end up paying for our drugs twice. We pay for the initial development through our tax dollars. And then when it goes on the market we pay their inflated prices.

Drug company payments to doctors are a small part of a much larger strategy by Big Pharma to clean our pockets.

You know the pharmaceutical industry. If they are involved with any deal with the government, they are not going to lose any money.

I believe that life-saving, essential drugs should be freely available and the innovator should be paid a suitable royalty payment for his invention.

While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.

Pharmaceutical companies are enjoying unprecedented profits and access with this Administration. Yet the Republicans' prescription drug plan for seniors has been a colossal failure, and over 43 million Americans wake up every morning without health insurance.

There are so few drugs for these killer diseases, but for erectile dysfunction, we have had 14 drugs since 1996… It says something about where the priorities of the pharmaceutical companies seem to lie.

The pharma industry is one of the few industries that comes up every year and brags about how much worse they got - like, now it costs $2 billion to make a drug, and it was a billion 5 years ago.

Blame me for capitalism. Blame me for EpiPen.

I think Trump's going to make it easier to be a drug company in America.

Private companies mostly manufacture medications that resemble what we've already got. They get it patented and, with a hefty dose of marketing, a legion of lawyers, and a strong lobby, can live off the profits for years.

I'd encourage more young people to apply their talents beyond finance and consulting and to think about reshaping how medicines are brought to market and how the business is run.

If my drug Ragaglitazar had been successful, we would have been getting royalties of thousands of crore rupees every year.

There's always going to be the need for new medications, better medications.

It is clear that the pharmaceutical industry is not, by any stretch of the imagination, doing enough to ensure that the poor have access to adequate medical care.

I've seen disgusting excess in business, and I've seen disgusting excess in Washington. But at the same time, I've certainly learned that Washington matters and that you can't ignore it, especially when you get into telecom.

Would-be drug companies must either produce medicines that stand up to federal scrutiny, demonstrate that their data has value to other companies, or go out of business.

We need to take politics out of health care. Congress will cave to pretty much any special interest on the subject.

Patients are becoming aware that they're being taken for a ride by big pharma companies. They charge high prices and have never cared for India's healthcare. There are 23 million cases of cancer every year and India has a fair share of that.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

I keep encouraging the pharmaceutical companies to put more money into R&D.

It's easy to complain that pharmaceutical companies place profits over people and apparently care more about hair loss than TB. However, many in the pharmaceutical industry would be glad for the opportunity to reorient their research toward medicines that are truly needed, provided only that such research is financially sustainable.

If you look at the world's top 50 drugs being sold today, they are being marketed and sold by companies that did not invent them. I respect patents. I'll pay a royalty. But I shouldn't be denied the right to produce drugs for poor people at reasonable prices.

While American taxes pay for much of the research and development that goes into creating the new, life-saving drugs, American consumers continue to subsidize the cost of the drugs for consumers across the world.